x

Search for a clinical trial

* (*) mandatory field

An Open-label, Multicenter, Efficacy and Safety Pilot Study of 6-month Canakinumab Treatment With up to 6-month Follow-up in Patients With Active Hyper-IgD Syndrome (HIDS) (Phase II) (Completed)

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Terminated trial
  • Funding body(ies) :
  • Geographic coverage : National
  • Sponsor : Novartis pharma services ag
  • Principal investigator of clinical trial

  • Dr Jordi ANTÓN LÓPEZ
  • Sección de Reumatología Pediátrica
  • Hospital Universitari Sant Joan de Déu
  • Paseo de Sant Joan de Déu, 2
  • 08950 ESPLUGUES DE LLOBREGAT
  • SPAIN
  • More information
  • Phone  : 34 93 600 97 90
  • Fax  : 34 93 253 21 31
  • Website
Last update: January 2015

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.